It is obvious that in the presence of nasolacrimal duct obstruction with purulent discharge, laser treatment is a better choice than anti‐VEGF injection in patients with ROP who needs treatment unless the patient became aggravated or has stage 4a ROP. The gene discussed is VEGFA; the disease is retinopathy of prematurity.